Charles Schwab Investment Management Inc. Increases Stock Position in Agilent Technologies, Inc. (NYSE:A)

Charles Schwab Investment Management Inc. raised its position in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 0.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,708,940 shares of the medical research company’s stock after buying an additional 8,151 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Agilent Technologies were worth $199,912,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC increased its holdings in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after acquiring an additional 270 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Agilent Technologies in the 4th quarter worth about $48,172,000. Sterling Capital Management LLC raised its position in Agilent Technologies by 51.9% in the 4th quarter. Sterling Capital Management LLC now owns 17,097 shares of the medical research company’s stock worth $2,297,000 after buying an additional 5,841 shares during the last quarter. Townsquare Capital LLC raised its position in Agilent Technologies by 33.5% in the 4th quarter. Townsquare Capital LLC now owns 2,593 shares of the medical research company’s stock worth $348,000 after buying an additional 651 shares during the last quarter. Finally, Sagespring Wealth Partners LLC purchased a new position in Agilent Technologies in the 4th quarter worth about $247,000.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on A shares. Robert W. Baird cut their price target on Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating for the company in a research note on Thursday, May 22nd. Leerink Partners lifted their price objective on Agilent Technologies to $135.00 and gave the company a “buy” rating in a research report on Friday, May 30th. Jefferies Financial Group lowered their price objective on Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research report on Monday, April 21st. UBS Group lowered their price objective on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a research report on Thursday, May 29th. Finally, JPMorgan Chase & Co. lowered their price target on Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 29th. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $139.77.

Check Out Our Latest Stock Analysis on Agilent Technologies

Agilent Technologies Stock Performance

Shares of A stock opened at $114.69 on Friday. The company has a market capitalization of $32.58 billion, a P/E ratio of 28.32, a P/E/G ratio of 3.48 and a beta of 1.22. The business’s 50 day moving average is $117.39 and its two-hundred day moving average is $119.43. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:AGet Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm’s revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.22 earnings per share. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st were paid a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is presently 24.44%.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business’s stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares of the company’s stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Read More

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.